(University of British Columbia) Researchers from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2W54cQs
No comments:
Post a Comment